Screener
Ironwood Pharmaceuticals IRWD Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Ironwood Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The source filing: Ironwood Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:07 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-091987
FAQ
- What is Ironwood Pharmaceuticals's net income?
- Ironwood Pharmaceuticals (IRWD) reported net income of $51.29M in Q2 2026.
- How has Ironwood Pharmaceuticals's net income changed year-over-year?
- Ironwood Pharmaceuticals's net income increased by 117.3% year-over-year, from $23.6M to $51.29M.
- What is the long-term trend for Ironwood Pharmaceuticals's net income?
- Over 4 years (2021 to 2025), Ironwood Pharmaceuticals's net income has grown at a -53.8% compound annual growth rate (CAGR), from $528.45M to $24.02M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.
Ask your AI about Ironwood Pharmaceuticals's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude